Introduction
Methods
Patients
Tissue microarray construction, immunohistochemistry and evaluation of MCM3 staining
Statistical analysis
Results
Distribution of MCM3 expression in primary and metastatic melanoma
Prognostic value of MCM3 expression and associaton with clinicopathological factors
MCM3 expression
| |||
---|---|---|---|
Factor
|
Low
|
High
|
P
|
n(%) | 133 (59.4) | 91 (40.6) | |
Age (continuous)
|
0.858
| ||
Mean | 67.36 | 67.25 | |
Median | 69.00 | 69.00 | |
Range | 46-81 | 47-83 | |
Location
|
0.893
| ||
Dorsal trunk | 33 (26.0) | 23 (25.6) | |
Frontal trunk | 16 (12.6) | 12 (13.3) | |
Arms | 22 (17.3) | 18 (20.0) | |
Legs | 37 (29.1) | 23 (25.6) | |
Head and neck | 19 (15.0) | 14 (15.6) | |
Unknown
|
6
|
1
| |
Histological subtype
|
0.003
| ||
SSM | 89 (66.9) | 53 (58.9) | |
LMM | 18 (13.5) | 5 (5.6) | |
NMM | 23 (17.3) | 30 (33.3) | |
Other | 3 (2.3) | 2 (2.2) | |
Unknown
|
1
| ||
Breslow thickness
|
<0.001
| ||
Mean | 1.48 | 1.94 | |
Median | 0.55 | 1.05 | |
Range | 0.08-40 | 0.15-14 | |
Unknown
|
1
|
1
| |
Breslow categories
|
<0.001
| ||
≤ 1 mm | 93 (70.5) | 44 (48.9) | |
1.1-2.0 mm | 19 (14.4) | 15 (16.7) | |
2.1-4.0 mm | 14 (10.6) | 23 (25.6) | |
> 4.0 mm | 6 (4.5) | 8 (8.9) | |
Unknown
|
1
|
1
| |
Clark level
|
<0.001
| ||
II | 58 (43.9) | 19 (21.3) | |
III | 58 (43.9) | 39 (43.8) | |
IV-V | 16 (12.1) | 31 (34.8) | |
Unknown
|
1
|
2
| |
Ulceration
|
<0.001
| ||
No | 122 (91.7) | 67 (74.4) | |
Yes | 11 (8.3) | 23 (25.6) | |
Unknown
|
1
| ||
Clinical stage
|
0.003
| ||
1 | 108 (91.5) | 50 (75.8) | |
2-4 | 10 (8.6) | 16 (24.2) | |
Unknown
|
15
|
24
| |
Vascular invasion
|
0.016
| ||
No | 129 (97.0) | 81 (89.0) | |
Yes | 4 (3.0) | 10 (11.0) | |
Mitotic count
|
<0.001
| ||
0/mm2 | 87 (65.4) | 27 (29.7) | |
> = 1/mm2 | 46 (34.6) | 64 (70.3) | |
Lymphocytic infiltrate
|
0.463
| ||
None-mild | 40 (30.5) | 23 (25.6) | |
Moderate-brisk | 93 (69.9) | 67 (74.4) | |
Unknown
|
1
| ||
Ki67 expression
|
0.001
| ||
Low | 100 (85.5) | 58 (65.9) | |
High | 17 (14.5) | 30 (34.1) | |
Unknown
|
16
|
3
| |
RBM3 expression
|
0.025
| ||
Low | 46 (37.4) | 48 (52.7) | |
High | 77 (62.6) | 43 (47.3) | |
Unknown
| 10 | 0 |
Risk of disease recurrence | Risk of death from melanoma | |||||
---|---|---|---|---|---|---|
Univariable | Multivariable | Univariable | Multivariable | |||
n (events) | HR (95%CI) | HR (95%CI) | n (events) | HR (95%CI) | HR (95%CI) | |
Age
| ||||||
Continuous | 255 (47) | 1.01 (0.97-1.05) | 255 (28) | 1.05 (0.99-1.10) | 1.08 (1.02-1.14) | |
Gender
| ||||||
Female | 132 (21) | 1,00 | 132 (9) | 1,00 | ||
Male | 123 (26) | 1.51 (0.85-2.70) | 123 (19) | 2.77 (1.25-6.14) | ||
Clark level
| ||||||
II | 93 (5) | 1,00 | 93 (2) | 1,00 | ||
III | 103 (21) | 4.39 (1.65-11.65) | 103 (14) | 7.16 (1.63-31.50) | ||
IV-V | 51 (21) | 9.99 (3.76-26.55) | 51 (12) | 12.91 (2.89-57.74) | ||
Breslow
| ||||||
Continuous | 248 (47) | 1.07 (1.03-1.11) | 248 (28) | 1.08 (1.03-1.13) | ||
Subtype
| ||||||
SSM, LMM, Other | 195 (22) | 1,00 | 195 (11) | 1,00 | 1.00 | |
Nodular | 53 (24) | 5.63 (3.15-10.08) | 53 (16) | 7.19 (3.32-15.57) | 5.51 (2.39-12.71) | |
Ulceration
| ||||||
No | 214 (30) | 1,00 | 214 (18) | 1,00 | ||
Yes | 35 (16) | 5.81 (3.13-10.80) | 35 (9) | 5.73 (2.59-12.97) | ||
Lymphocytic
| ||||||
infiltrate
| ||||||
0-1 | 72 (20) | 1,00 | 72 (11) | 1,00 | ||
2-3 | 176 (26) | 0.43 (0.24-0.78) | 176 (16) | 0.50 (0.23-1.08) | ||
Clinical stage
| ||||||
I | 179 (12) | 1,00 | 1,00 | 179 (7) | 1,00 | |
II-IV | 28 (13) | 15.02 (6.39-35.30) | 12.03 (4.49-32.28) | 28 (8) | 14.09 (4.82-41.18) | |
Mitotic count
| ||||||
<1/mm2 | 131 (7) | 1,00 | 131 (3) | 1,00 | ||
> = 1/mm2 | 122 (40) | 7.96 (3.56-17.80) | 122 (25) | 11.25 (3.39-37.36) | ||
Vascular invasion
| ||||||
No | 232 (35) | 1,00 | 1,00 | 232 (18) | 1,00 | 1.00 |
Yes | 14 (11) | 9.25 (1.67-7.60) | 3.56 (2.35-10.92) | 14 (9) | 11.29 (5.05-25.25) | 8.26 (3.30-20.67) |
Ki67 expression
| ||||||
Low (<=25 %) | 159 (28) | 1,00 | 159 (16) | 1,00 | ||
High (>25 %) | 47 (16) | 2.46 (1.33-4.56) | 47 (10) | 2.64 (1.20-5.83) | ||
RBM3 expression
| ||||||
Low | 95 (24) | 1.00 | 95 (17) | 1.00 | 1.00 | |
High | 120 (20) | 0.50 (0.27-0.91) | 120(9) | 0.29 (0.13-0.66) | 0.30 (0.14-0.71) | |
MCM3 expression
| ||||||
Low (N ≤ S3) | 133 (11) | 1.00 | 1.00 | 133 (6) | 1.00 | 1.00 |
High (NS > 3) | 91 (34) | 5.62 (2.83-11.13) | 5.01 (0.33-10.79) | 91 (21) | 6.03 (2.42-15.02) | 4.96 (1.77-13.87) |